Banco Bilbao Vizcaya Argentaria’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
14,156
+11,047
| +355% | +$1.68M | 0.02% | 395 |
|
|
2025
Q1 | $465K | Buy |
3,109
+879
| +39% | +$132K | ﹤0.01% | 611 |
|
|
2024
Q4 | $411K | Sell |
2,230
-657
| -23% | -$121K | ﹤0.01% | 615 |
|
|
2024
Q3 | $569K | Sell |
2,887
-410
| -12% | -$80.8K | 0.01% | 606 |
|
|
2024
Q2 | $683K | Sell |
3,297
-734
| -18% | -$152K | 0.01% | 584 |
|
|
2024
Q1 | $1.09M | Buy |
4,031
+1,449
| +56% | +$393K | 0.01% | 533 |
|
|
2023
Q4 | $609K | Buy |
2,582
+219
| +9% | +$51.7K | 0.01% | 613 |
|
|
2023
Q3 | $463K | Buy |
2,363
+921
| +64% | +$181K | 0.01% | 633 |
|
|
2023
Q2 | $303K | Sell |
1,442
-109
| -7% | -$22.9K | ﹤0.01% | 670 |
|
|
2023
Q1 | $313K | Buy |
1,551
+281
| +22% | +$56.7K | ﹤0.01% | 671 |
|
|
2022
Q4 | $277K | Buy |
1,270
+57
| +5% | +$12.4K | ﹤0.01% | 666 |
|
|
2022
Q3 | $239K | Sell |
1,213
-17
| -1% | -$3.35K | ﹤0.01% | 683 |
|
|
2022
Q2 | $263K | Buy |
1,230
+122
| +11% | +$26.1K | ﹤0.01% | 650 |
|
|
2022
Q1 | $321K | Sell |
1,108
-155
| -12% | -$44.9K | ﹤0.01% | 657 |
|
|
2021
Q4 | $475K | Buy |
1,263
+28
| +2% | +$10.5K | 0.01% | 677 |
|
|
2021
Q3 | $510K | Buy |
1,235
+25
| +2% | +$10.3K | 0.01% | 612 |
|
|
2021
Q2 | $448K | Buy |
+1,210
| New | +$448K | 0.01% | 639 |
|